Studies have shown that MAO-B is upregulated in key brain regions of AD patients, such as the frontal cortex, hippocampal CA1 region, and entorhinal cortex, where it promotes Aβ production and accumulation, thereby accelerating neuronal damage [6]. The gene discussed is MAOB; the disease is Alzheimer disease.